Authors: Hatzakis, A Gargalianos, P Kiosses, V Lazanas, M Sypsa, V Anastassopoulou, C Vigklis, V Sambatakou, H Botsi, C Paraskevis, D Stalgis, C

Citation: A. Hatzakis et al., Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication, J INTERF CY, 21(10), 2001, pp. 861-869

Authors: Bekkering, FC Stalgis, C McHutchison, JG Brouwer, JT Perelson, AS

Citation: Fc. Bekkering et al., Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model, HEPATOLOGY, 33(2), 2001, pp. 419-423

Authors: Buti, M Morral, S Sanchez, F Martell, M Stalgis, C Esteban, R

Citation: M. Buti et al., High-dose interferon-alpha(2b) plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus, DIG DIS SCI, 46(11), 2001, pp. 2396-2400

Authors: Buti, M Olive, G Stalgis, C Esteban, R Guardi, J

Citation: M. Buti et al., Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis C, DIG DIS SCI, 45(4), 2000, pp. 685-689